NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · SMALL CAP
Jin Medical International Ltd. ZJYL
5 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$20.7M
▼ 12.0% vs FY2024
EPS · FY25
$0.01
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
4.1%
Net margin · FY25
5.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 20.7M
Revenue, FY2025 · full 5-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 0.01
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
4.1%
Return on equity, FY2025
ROE
Operating margin2.9%
Net margin5.8%
Return on assets2.4%
Each USD of equity produced 4 cents of profit this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+2.5%
Net income
−23.9%
EPS, diluted
−20.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.16B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 53.4M
total assets, end of FY2025
Total assetsUSD 53.4M
EquityUSD 29.6M
CashUSD 7.5M
Gross debtUSD 18.8M
Net debtUSD 11.4M
Current ratio1.86×
Net debt stands at 38% of equity.
History
5 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
Revenue $B
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
0.01
0.02
0.02
0.02
0.02
Dividend / sh $
·
·
·
·
·
Payout %
·
·
·
·
·
ROE %
4.1
13.9
14.7
17.8
·
Shares out B
0.16
0.16
0.16
0.14
0.14
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
18 of 18
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed